Drugplain

Pramipexole Dihydrochloride Extended-Release .375 mg/1

Pramipexole Dihydrochloride · TABLET, EXTENDED RELEASE · Vitruvias Therapeutics, Inc.

No Recall History
Plain English

Pramipexole dihydrochloride extended-release is a prescription oral tablet used to treat Parkinson's disease and restless legs syndrome. This medication works by stimulating dopamine receptors in the brain to help improve movement and reduce uncomfortable sensations in the legs.

Key Facts

Brand Name
Pramipexole Dihydrochloride Extended-Release
Generic Name
Pramipexole Dihydrochloride
NDC Code (Product)
69680-145
Manufacturer
Vitruvias Therapeutics, Inc.
Strength
.375 mg/1
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Marketing Status
Application #
ANDA212797
Marketing Start
08/27/2021

Recall History

No Recall History

Frequently Asked Questions

What is Pramipexole Dihydrochloride Extended-Release used for?

Pramipexole dihydrochloride extended-release is a prescription oral tablet used to treat Parkinson's disease and restless legs syndrome. This medication works by stimulating dopamine receptors in the brain to help improve movement and reduce uncomfortable sensations in the legs.

Is Pramipexole Dihydrochloride Extended-Release a controlled substance?

Pramipexole Dihydrochloride Extended-Release is not classified as a controlled substance by the DEA.

What is the generic name for Pramipexole Dihydrochloride Extended-Release?

The generic name for Pramipexole Dihydrochloride Extended-Release is Pramipexole Dihydrochloride. There are 12 other brand versions of Pramipexole Dihydrochloride.

What is the NDC code for Pramipexole Dihydrochloride Extended-Release .375 mg/1?

The NDC (National Drug Code) for Pramipexole Dihydrochloride Extended-Release .375 mg/1 is 69680-145, listed by Vitruvias Therapeutics, Inc..